Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05933681 · ClinicalTrials.gov registry record · NA

Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

A NA study of Parkinson Disease, sponsored by Vanderbilt University Medical Center.

Active
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT05933681 is a NA study of Parkinson Disease that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 160 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05933681, a NA study of Parkinson Disease, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The study aims to investigate cognitive impairment associated with Deep Brain Stimulation (DBS) in Parkinson's Disease patients, with a focus on identifying neurophysiology biomarkers of DBS associated cognitive changes. Using neurophysiology data recorded during DBS surgeries and post-implantation, the research intends to identify biomarkers in order to optimize electrode placement, enhance programming, and ultimately minimize DBS-related cognitive side effects.

Conditions Studied

Interventions

  • DEVICE Neural recordings and stimulation

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2023-07-06
Est. Completion 2026-05-30
Phase NA

What the Registry Record Tells You About NCT05933681

The ClinicalTrials.gov registry entry for NCT05933681 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (97% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Neural recordings and stimulation is the first listed.

NCT05933681 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05933681 about?

NCT05933681 is a clinical study titled "Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation". The study aims to investigate cognitive impairment associated with Deep Brain Stimulation (DBS) in Parkinson's Disease patients, with a focus on identifying neurophysiology biomarkers of DBS associated cognitive changes. Using neurophysiology data recorded during DBS surgeries and post-implantation,...

What is the current status of trial NCT05933681?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2023-07-06. Estimated completion is 2026-05-30.

What conditions does trial NCT05933681 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05933681?

The interventions under investigation include: Neural recordings and stimulation (DEVICE).

Who is sponsoring clinical trial NCT05933681?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05933681 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.